S&P 500   4,352.13 (-1.14%)
DOW   34,231.56 (-0.61%)
QQQ   359.69 (-1.33%)
AAPL   174.56 (-0.53%)
MSFT   320.71 (-0.02%)
META   297.44 (-0.74%)
GOOGL   131.18 (-1.91%)
AMZN   130.20 (-3.76%)
TSLA   256.81 (-2.20%)
NVDA   413.87 (-2.02%)
NIO   8.48 (-3.85%)
BABA   84.19 (-1.81%)
AMD   96.65 (-3.68%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.31 (-1.97%)
CGC   0.77 (-11.53%)
GE   113.62 (-1.07%)
DIS   82.63 (+0.08%)
AMC   7.75 (-5.02%)
PFE   32.95 (-1.99%)
PYPL   58.80 (-3.38%)
NFLX   384.99 (-0.34%)
S&P 500   4,352.13 (-1.14%)
DOW   34,231.56 (-0.61%)
QQQ   359.69 (-1.33%)
AAPL   174.56 (-0.53%)
MSFT   320.71 (-0.02%)
META   297.44 (-0.74%)
GOOGL   131.18 (-1.91%)
AMZN   130.20 (-3.76%)
TSLA   256.81 (-2.20%)
NVDA   413.87 (-2.02%)
NIO   8.48 (-3.85%)
BABA   84.19 (-1.81%)
AMD   96.65 (-3.68%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.31 (-1.97%)
CGC   0.77 (-11.53%)
GE   113.62 (-1.07%)
DIS   82.63 (+0.08%)
AMC   7.75 (-5.02%)
PFE   32.95 (-1.99%)
PYPL   58.80 (-3.38%)
NFLX   384.99 (-0.34%)
S&P 500   4,352.13 (-1.14%)
DOW   34,231.56 (-0.61%)
QQQ   359.69 (-1.33%)
AAPL   174.56 (-0.53%)
MSFT   320.71 (-0.02%)
META   297.44 (-0.74%)
GOOGL   131.18 (-1.91%)
AMZN   130.20 (-3.76%)
TSLA   256.81 (-2.20%)
NVDA   413.87 (-2.02%)
NIO   8.48 (-3.85%)
BABA   84.19 (-1.81%)
AMD   96.65 (-3.68%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.31 (-1.97%)
CGC   0.77 (-11.53%)
GE   113.62 (-1.07%)
DIS   82.63 (+0.08%)
AMC   7.75 (-5.02%)
PFE   32.95 (-1.99%)
PYPL   58.80 (-3.38%)
NFLX   384.99 (-0.34%)
S&P 500   4,352.13 (-1.14%)
DOW   34,231.56 (-0.61%)
QQQ   359.69 (-1.33%)
AAPL   174.56 (-0.53%)
MSFT   320.71 (-0.02%)
META   297.44 (-0.74%)
GOOGL   131.18 (-1.91%)
AMZN   130.20 (-3.76%)
TSLA   256.81 (-2.20%)
NVDA   413.87 (-2.02%)
NIO   8.48 (-3.85%)
BABA   84.19 (-1.81%)
AMD   96.65 (-3.68%)
T   15.35 (-1.29%)
F   12.19 (-1.38%)
MU   68.31 (-1.97%)
CGC   0.77 (-11.53%)
GE   113.62 (-1.07%)
DIS   82.63 (+0.08%)
AMC   7.75 (-5.02%)
PFE   32.95 (-1.99%)
PYPL   58.80 (-3.38%)
NFLX   384.99 (-0.34%)
NYSE:IVC

Invacare (IVC) Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.35
$0.74
52-Week Range
N/A
Volume
33,301 shs
Average Volume
240,305 shs
Market Capitalization
$20.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Invacare MarketRank™ Forecast

Analyst Rating
0.00 Rating Score
Upside/​Downside
∞ Upside
$2.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-0.81
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.76) to ($1.59) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.58 out of 5 stars

Medical Sector

886th out of 961 stocks

Surgical Appliances & Supplies Industry

18th out of 19 stocks


IVC stock logo

About Invacare (NYSE:IVC) Stock

Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. It focuses on medical device solutions for congenital, acquired, and degenerative ailments. The firm operates through the following segments: North America and Europe. The company was founded by Aaron Malachi Mixon III in 1979 and is headquartered in Elyria, OH.


IVC Stock News Headlines

From Naval Flight Officer to CEO
First Female Founded, Publicly Traded, Space Company. Discover more
Invacare Reports Results for First Quarter 2023
Invacare files for bankruptcy
From Naval Flight Officer to CEO
First Female Founded, Publicly Traded, Space Company. Discover more
Why Is Invacare (IVC) Stock Down 20% Today?
Invacare draws more on term loan from hedge fund manager
Invacare picks Geoff Purtill as permanent president, CEO
Invacare Third Quarter 2022 Earnings: Misses Expectations
Invacare Reports Results for Third Quarter 2022
See More Headlines
Receive IVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.

IVC Company Calendar

Last Earnings
10/27/2021
Today
9/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
46120310
Employees
3,000
Year Founded
1885

Price Target and Rating

Average Stock Price Forecast
$2.00
High Stock Price Forecast
$2.00
Low Stock Price Forecast
$2.00
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-45,560,000.00
Pretax Margin
-9.38%

Debt

Sales & Book Value

Annual Sales
$872.46 million
Book Value
$5.54 per share

Miscellaneous

Free Float
35,153,000
Market Cap
$20.01 million
Optionable
Optionable
Beta
0.38

Social Links

Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Geoffrey P. Purtill
    President, Chief Executive Officer & Director
  • Kathleen Patricia Leneghan
    Senior VP, Chief Financial & Accounting Officer
  • Angie Goodwin
    SVP, Chief Technology & Information Officer
  • Joost Beltman
    Senior VP & General Manager-North America
  • Anthony C. LaPlacaAnthony C. LaPlaca
    Secretary, Chief Administrative Officer & SVP













IVC Stock - Frequently Asked Questions

What is Invacare's stock price forecast for 2023?

0 Wall Street research analysts have issued 1-year target prices for Invacare's shares. Their IVC share price forecasts range from $2.00 to $2.00. On average, they predict the company's share price to reach $2.00 in the next twelve months.
View analysts price targets for IVC
or view top-rated stocks among Wall Street analysts.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) announced its quarterly earnings data on Wednesday, October, 27th. The health services provider reported ($0.12) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.20) by $0.08. The health services provider earned $224.20 million during the quarter, compared to the consensus estimate of $222.27 million. Invacare had a negative net margin of 9.99% and a negative trailing twelve-month return on equity of 37.76%. During the same quarter in the previous year, the firm posted ($0.10) EPS.

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare Chief Executive Officer Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among the company's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Who are Invacare's major shareholders?

Invacare's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Simplex Trading LLC (0.00%). Insiders that own company stock include Anthony Laplaca, Baiju R Shah, Kathleen P Leneghan, Matthew E Monaghan and Steven H Rosen.
View institutional ownership trends
.

How much money does Invacare make?

Invacare (NYSE:IVC) has a market capitalization of $0.00 and generates $872.46 million in revenue each year. The health services provider earns $-45,560,000.00 in net income (profit) each year or ($2.18) on an earnings per share basis.

How many employees does Invacare have?

The company employs 3,000 workers across the globe.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The official website for the company is www.invacare.com. The health services provider can be reached via phone at (440) 329-6000, via email at loislee@invacare.com, or via fax at 877-619-7996.

This page (NYSE:IVC) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -